Generation of a PDGFRB-mCherry knock-in reporter human induced pluripotent stem cell line (KITi001-A-1), using CRISPR/Cas9 nuclease

被引：1
|
作者：
Jo, Seongyea [1 ,2 ]
Kim, Ji-Woo [1 ]
Noh, Haneul [1 ]
Kim, Hyemin [1 ]
Kim, Jong-Hoon [2 ]
Park, Han-Jin [1 ]
机构：
[1] Korea Inst Toxicol, Dept Predict Toxicol, Daejeon, South Korea
[2] Korea Univ, Coll Life Sci & Biotechnol, Dept Biotechnol, Lab Stem Cells & Tissue Regenerat, Seoul, South Korea
来源：
STEM CELL RESEARCH | 2023年 / 69卷
关键词：
D O I：
10.1016/j.scr.2023.103081
中图分类号：
Q813 [细胞工程];
学科分类号：
摘要：
PDGFRB encodes platelet-derived growth factor receptor beta (PDGFR-beta), a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. It is required for the normal development of the vascular and nervous systems and rearrangement of the actin cytoskeleton. PDGFR-beta plays an essential role in early liver diseases, including liver fibrosis. Here, we generated a human induced pluripotent stem cell (iPSC) line, KITi001-A-1, using CRISPR/Cas9. This reporter iPSC line and its derivatives are useful for tracing PDGFR-beta-expressing cells and for screening for liver fibrosis-inducing compounds.
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Generation of a TRPV1 knockout human pluripotent stem cell line (WAe009-A-U) using CRISPR/Cas9
    Cao, Yuhong
    Tang, Ling
    Su, Jun
    Wang, Hao
    Liang, Ping
    Rong, Kuang
    Gong, Tingyu
    STEM CELL RESEARCH, 2023, 72
  • [42] MODELING AUTISM USING CRISPR/CAS9 AND HUMAN INDUCED PLURIPOTENT STEM CELLS
    Deneault, Eric
    Zaslaysky, Kirill
    Thompson, Tadeo
    Ellis, James
    Scherer, Stephen
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S161 - S161
  • [43] Generation of an ASGR1 homozygousmutant human embryonic stem cell line WAe001-A-6 using CRISPR/Cas9
    Xu, Yingying
    Wu, Yuhang
    Guo, Dongsheng
    Gao, Ge
    Lai, Keyu
    Yang, Fan
    Wang, Kepin
    Wu, Han
    Lai, Liangxue
    Li, Jialiang
    Xu, Kecheng
    Li, Yin-Xiong
    STEM CELL RESEARCH, 2017, 22 : 29 - 32
  • [44] Generation of a lamin A/C knockout human induced pluripotent stem cell line (ZJULLi007-A) via CRISPR/Cas9
    Liu, Dandan
    Shen, Jiaxi
    Yang, Zongkuai
    Fan, Hangping
    Wang, Hao
    Liang, Ping
    Gong, Tingyu
    STEM CELL RESEARCH, 2024, 81
  • [45] Establishment of a TLR3 homozygous knockout human induced pluripotent stem cell line using CRISPR/Cas9
    Han, Hyeong-jun
    Kim, Jung-Hyun
    STEM CELL RESEARCH, 2021, 52
  • [46] Generation of a homozygous ZBTB7A knockout human induced pluripotent stem line by CRISPR/Cas9 editing
    Chen, Diyu
    Song, Bing
    Cheng, Yi
    Zhu, Lifen
    Lu, Dian
    Liu, Nengqing
    Yang, Yinghong
    Sun, Xiaofang
    STEM CELL RESEARCH, 2021, 55
  • [47] Generation of a PPM1A-deficient human induced pluripotent stem cell line using CRISPR-Cas9 technology
    Guo, Xinrui
    Zhao, Kui
    Zhang, Yanqi
    Zhou, Tiancheng
    Pan, Guangjin
    STEM CELL RESEARCH, 2024, 77
  • [48] Generation of targeted overexpressing models by CRISPR/Cas9 and need of careful validation of your knock-in line obtained by nuclease genome editing
    Pavlovic, Guillaume
    Erbs, Valerie
    Andre, Philippe
    Sylvie, Jacquot
    Eisenman, Benjamin
    Dreyer, Dominique
    Lorentz, Romain
    Wattenhofer-Donze, Marie
    Birling, Marie-Christine
    Herault, Yann
    TRANSGENIC RESEARCH, 2016, 25 (02) : 254 - 255
  • [49] Generation of an OCT4 reporter human induced pluripotent stem cell line using CRISPR/SpCas9
    Balboa, Diego
    Weltner, Jere
    Novik, Yuval
    Eurola, Solja
    Wartiovaara, Kirmo
    Otonkoski, Timo
    STEM CELL RESEARCH, 2017, 23 : 105 - 108
  • [50] Generation of a SOX2 reporter human induced pluripotent stem cell line using CRISPR/SaCas9
    Balboa, Diego
    Weltner, Jere
    Novik, Yuval
    Eurola, Solja
    Wartiovaara, Kirmo
    Otonkoski, Timo
    STEM CELL RESEARCH, 2017, 22 : 16 - 19
12345